Tag: stelara

stelara

Latest News

Samsung Bioepis headquarters in Songdo, Incheon [SAMSUNG BIOEPIS]

Samsung, Sandoz sign deal to commercialize biosimilar SB17

Samsung Bioepis signed an agreement with Switzerland’s Sandoz for the sales of its Stelara biosimilar drug in the North American and European regions.

2023.9.11

Celltrion headquarters in Incheon [CELLTRION]

Celltrion reaches patent agreement for Stelara biosimilar CT-P43

Celltrion reached a patent agreement for its copycat drug of Stelara, a blockbuster psoriasis treatment by Janssen Pharmaceuticals, with Janssen’s parent company Johnson & Johnson (J&J).

2023.8.25

Dong-A ST and Meiji Seika sign ustekinumab deal with Intas

Dong-A ST and Tokyo’s Meiji Seika Pharma have signed a deal with Ahmedabad, India’s Intas Pharmaceuticals to license DMB-3115, biosimilar referencing psoriasis treatment Stelara, the Korean company announced Wednesday.

2021.7.21

A Samsung Bioepis researcher conducts tests at the company’s lab in Incheon. [SAMSUNG BIOEPIS]

Samsung Bioepis starts Phase 3 trials on SB17

SB17, a Samsung Bioepis biosimilar referencing psoriasis treatment Stelara, is in Phase 3 clinical trials, the company said Tuesday.

2021.7.20

Tag: stelara

stelara

Latest News

Samsung, Sandoz sign deal to commercialize biosimilar SB17

Celltrion reaches patent agreement for Stelara biosimilar CT-P43

Most popular

Veteran actors Yoo Hae-jin, Ryu Seung-ryong win Baeksang Grand Prizes — as it happened

Rooney, Maicon, Park Joo-ho score as Shield United wins Icons Match in Seoul — as it happened

BTS comeback: Bright lights and drone shows light up the sky as 'Arirang' finally arrives — as it happened

179 dead after Jeju Air flight 7C2216 crashes at Muan International Airport — as it happened

Yoon Suk Yeol sentenced to life in prison for insurrection — as it happened

Dong-A ST and Meiji Seika sign ustekinumab deal with Intas

Samsung Bioepis starts Phase 3 trials on SB17